Vivo Bio Tech Ltd.
Snapshot View

80.80 -1.10 ▼-1.3%

26 July 2021, 04:00:00 P.M.
Volume: 14,179

Overview View Details

Sector Miscellaneous Compare with Sector peers
Industry Miscellaneous Compare with Industry peers
Website http://www.vivobio.com
Financial Indicators
Market Cap 116.34 Cr.
Earnings per share (EPS) 4.00 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) 20.47 Trailing Twelve Months Ending 2021-03
Industry PE 100.55 Trailing Twelve Months Ending 2021-03
Book Value / Share 31.05 Trailing Twelve Months Ending 2021-03
Price to Book Value 2.64 Calculated using Price: 81.90
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 1.42 Cr. 14,204,520 Shares
FaceValue 10
Company Profile

Vivo Bio Tech was incorporated on February 12, 1987 as Golden Growth Fund, Hyderabad-based Vivo Bio Tech (VBTL) is a contract research company engaged in biotechnology and pharma drug discovery activities. The company was converted into a public limited company from Jun. 19, 1992. VBTL provides services ranging from insilico design, wet lab contract research, preclinical research and clinical studies spanning the entire drug discovery value chain.

It is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD, AAALAC & IND guidelines. The company offers services in the areas of custom research, In-vitro and In-vivo toxicity studies, pharmacological investigations, pharmacokinetics & toxicokinetic studies etc. Our experienced & talented scientists offer advice on defining drug development paths tailored to specific molecules. Tailored and dedicated to our clients, we distinguish your development plan is as superlative as the products you bring to our testing facilities.

The Custom Research Services group at Vivo Bio Tech offers a complete line of protein services, including gene synthesis, cloning, expression and purification of recombinant proteins and monoclonal antibodies. Our scientists will team up with you to develop solution for the most difficult to deal products including purification of untagged & poorly expressed proteins.

In-vitro Services offers solutions for pharmacologic, toxicological & bioanalytical investigations in drug discovery & development. Critical investigations like bacterial reverse mutation assays, chromosomal aberration, and micronucleus are specialty services by our scientists.

Vivo Bio Tech has obtained permission from the Govt. of India for developing Biotech Sector Specific 'Special Economic Zone' at its site (39 acres) in Pregnapur, Gajwel Mandal, Medak District, Andhra Pradesh.The Vivo Bio Tech SEZ is located adjacent to Karimnagar highway road (approx 16 km from ICICI Knowledge Park and SP Biotech Park). The site is approximately 53km from Secunderabad Railway Station and around 90km from the new airport (Shamshabad).

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
-1.34%
1 Week
-3.58%
1 Month
-8.86%
3 Month
+21.50%
6 Month
+62.25%
1 Year
+176.24%
2 Year
+138.35%
5 Year
+97.07%
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) 15.61 5.91 3.52 5.25 9.48 22.17 21.01 10.21 14.85
Return on Capital Employed (%) 11.92 7.83 7.95 4.72 5.96 12.39 15.18 9.58 13.85
Return on Assets (%) 1.36 0.83 0.75 1.14 2.09 5.17 5.64 3.92 7.58

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 5 8 9 9 10 13 19 27 33
Non Curr. Liab. 22 5 5 4 15 22 15 9 9
Curr. Liab. 28 26 26 28 20 17 25 19 21
Minority Int.
Equity & Liab. 54 39 40 41 46 51 60 55 62
Non Curr. Assets 44 21 21 20 24 32 32 30 35
Curr. Assets 10 18 19 22 22 20 28 25 27
Misc. Exp. not W/O 0 0 0 0 0 0 0 0 0
Total Assets 54 39 40 41 46 51 60 55 62

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 12 14 16 18 29 34 47 56 55
Other Income 0 1 1 1 1 0 0 0 0
Total Income 13 15 17 19 29 35 47 56 55
Total Expenditure -7 -12 -14 -15 -25 -27 -36 -46 -43
PBIDT 5 3 3 4 5 8 11 10 13
Interest -3 -1 0 -1 0 -1 -2 -3 -3
Depreciation -2 -2 -2 -3 -3 -4 -5 -5 -5
Taxation 1 0 0 0 0 0 -1 0 0
Exceptional Items
PAT 1 0 0 0 1 3 3 2 4

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 5 2 3 2 9 -6 11 -1 9
Cash Fr. Inv. -5 25 -1 -2 -7 -12 -5 -4 -10
Cash Fr. Finan. 0 -19 0 -1 0 7 -3 1 2
Net Change 0 8 1 -1 1 -11 3 -4 0
Cash & Cash Eqvt 2 10 11 11 12 1 4 1 1

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 35.07 35.07 34.70 34.70 34.70 34.70 34.70 36.58 39.84
Public 64.93 64.93 65.30 65.30 65.30 65.30 65.30 63.42 60.16
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Fri, 23 Jul 2021
Regulation 23(9)-Disclosure Of Related Party Transactions On Consolidated Basis For The Year Ended 31St March 2021.
Please find enclosed the disclosure under Regulation 23(9)-Disclosure of Related party transactions on consolidated basis for the year ended on 31st march 2021.
Mon, 12 Jul 2021
Shareholding for the Period Ended June 30 2021
Vivo Bio Tech Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30 2021. For more details kindly Click here
Fri, 09 Jul 2021
Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0000
Name of the Signatory :- A KARTHIK
Designation :- Company Secretary and Compliance Officer

Technical Scans View Details

Fri, 23 Jul 2021
Decreasing Relative Strength - Benchmark index Decreasing Relative Strength - Benchmark index
Both SRS And ARS Above Zero Both SRS And ARS Above Zero
Thu, 22 Jul 2021
Strongly Outperforming Benchmark Index Strongly Outperforming Benchmark Index
Both SRS And ARS Above Zero Both SRS And ARS Above Zero
Stochastic Trending Down Stochastic Trending Down

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Syngene International Ltd. 25,162.00 629.00 +0.2%
Quess Corp Ltd. 11,787.84 797.00 -0.3%
RattanIndia Enterprises Ltd. 8,860.35 67.30 +5.0%
SIS Ltd. 7,216.06 518.75 +5.4%
Sun Pharma Advanced Research Company Ltd. 6,962.60 260.45 -2.0%
TeamLease Services Ltd. 6,775.02 4,009.00 +1.4%
Just Dial Ltd. 6,044.08 964.70 -0.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Syngene International Ltd. Consolidated 2021-06 59.32 629.00 +0.2%
Quess Corp Ltd. Consolidated 2021-03 203.67 797.00 -0.3%
RattanIndia Enterprises Ltd. Consolidated 2021-03 0.00 67.30 +5.0%
SIS Ltd. Consolidated 2021-03 19.75 518.75 +5.4%
Sun Pharma Advanced Research Company Ltd. Standalone 2021-03 0.00 260.45 -2.0%
TeamLease Services Ltd. Consolidated 2021-03 87.42 4,009.00 +1.4%
Just Dial Ltd. Consolidated 2021-06 47.47 964.70 -0.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Syngene International Ltd. Consolidated 2021-06 8.91 629.00 +0.2%
Quess Corp Ltd. Consolidated 2021-03 5.03 797.00 -0.3%
RattanIndia Enterprises Ltd. Consolidated 2021-03 104.43 67.30 +5.0%
SIS Ltd. Consolidated 2021-03 4.19 518.75 +5.4%
Sun Pharma Advanced Research Company Ltd. Standalone 2021-03 -41.01 260.45 -2.0%
TeamLease Services Ltd. Consolidated 2021-03 10.40 4,009.00 +1.4%
Just Dial Ltd. Consolidated 2021-06 4.79 964.70 -0.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Syngene International Ltd. Consolidated 2021-03 0.28 629.00 +0.2%
Quess Corp Ltd. Consolidated 2020-03 0.51 797.00 -0.3%
RattanIndia Enterprises Ltd. Consolidated 2020-03 0.00 67.30 +5.0%
SIS Ltd. Consolidated 2021-03 0.74 518.75 +5.4%
Sun Pharma Advanced Research Company Ltd. Standalone 2020-03 -3.67 260.45 -2.0%
TeamLease Services Ltd. Consolidated 2020-03 0.14 4,009.00 +1.4%
Just Dial Ltd. Consolidated 2020-03 0.00 964.70 -0.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Syngene International Ltd. Consolidated 2021-03 16.59 629.00 +0.2%
Quess Corp Ltd. Consolidated 2020-03 -16.80 797.00 -0.3%
RattanIndia Enterprises Ltd. Consolidated 2020-03 -0.24 67.30 +5.0%
SIS Ltd. Consolidated 2021-03 23.02 518.75 +5.4%
Sun Pharma Advanced Research Company Ltd. Standalone 2020-03 -225.08 260.45 -2.0%
TeamLease Services Ltd. Consolidated 2020-03 6.75 4,009.00 +1.4%
Just Dial Ltd. Consolidated 2020-03 24.85 964.70 -0.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Syngene International Ltd. Consolidated 2021-03 15.40 629.00 +0.2%
Quess Corp Ltd. Consolidated 2020-03 -5.79 797.00 -0.3%
RattanIndia Enterprises Ltd. Consolidated 2020-03 0.63 67.30 +5.0%
SIS Ltd. Consolidated 2021-03 21.05 518.75 +5.4%
Sun Pharma Advanced Research Company Ltd. Standalone 2020-03 -178.22 260.45 -2.0%
TeamLease Services Ltd. Consolidated 2020-03 16.25 4,009.00 +1.4%
Just Dial Ltd. Consolidated 2020-03 31.48 964.70 -0.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Syngene International Ltd. Consolidated 2021-03 2,184.30 629.00 +0.2%
Quess Corp Ltd. Consolidated 2020-03 10,991.48 797.00 -0.3%
RattanIndia Enterprises Ltd. Consolidated 2020-03 67.30 +5.0%
SIS Ltd. Consolidated 2021-03 9,127.30 518.75 +5.4%
Sun Pharma Advanced Research Company Ltd. Standalone 2020-03 76.81 260.45 -2.0%
TeamLease Services Ltd. Consolidated 2020-03 5,200.72 4,009.00 +1.4%
Just Dial Ltd. Consolidated 2020-03 953.11 964.70 -0.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Syngene International Ltd. Consolidated 2021-03 404.90 629.00 +0.2%
Quess Corp Ltd. Consolidated 2020-03 -418.05 797.00 -0.3%
RattanIndia Enterprises Ltd. Consolidated 2020-03 -0.38 67.30 +5.0%
SIS Ltd. Consolidated 2021-03 366.66 518.75 +5.4%
Sun Pharma Advanced Research Company Ltd. Standalone 2020-03 -312.40 260.45 -2.0%
TeamLease Services Ltd. Consolidated 2020-03 37.06 4,009.00 +1.4%
Just Dial Ltd. Consolidated 2020-03 272.31 964.70 -0.5%